Clearstead Advisors’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$561K Buy
46,996
+21,199
+82% +$256K 0.01% 722
2026
Q1
$292K Buy
25,797
+9,296
+56% +$111K ﹤0.01% 874
2025
Q4
$210K Sell
16,501
-1,162
-7% -$15.5K ﹤0.01% 929
2025
Q3
$231K Sell
17,663
-11,084
-39% -$153K ﹤0.01% 847
2025
Q2
$393K Buy
28,747
+1,118
+4% +$15.8K 0.01% 670
2025
Q1
$424K Buy
27,629
+715
+3% +$11.2K 0.01% 622
2024
Q4
$411K Sell
26,914
-14,373
-35% -$230K 0.01% 629
2024
Q3
$673K Sell
41,287
-8,700
-17% -$149K 0.01% 502
2024
Q2
$940K Buy
+49,987
New +$966K 0.02% 406

Other funds holding OCSL

Clearstead Advisors's OCSL Position: Q2 2026 in Review

Clearstead Advisors increased its Oaktree Specialty Lending (OCSL) stake by 82% in Q2 2026, buying an estimated $256K and bringing the position to 46,996 shares worth $561K. The position accounts for 0.01% of the portfolio, ranked #722.

Clearstead Advisors first reported a position in OCSL in Q2 2024 and has held it in 9 quarters since. The position peaked at $940K in Q2 2024. 165 funds tracked by Wall St. Rank hold OCSL as of Q2 2026.

  • Clearstead Advisors held 46,996 shares of Oaktree Specialty Lending worth $561K as of Q2 2026.
  • Clearstead Advisors bought 21,199 Oaktree Specialty Lending shares in Q2 2026, an estimated $256K.
  • Oaktree Specialty Lending made up 0.01% of Clearstead Advisors's portfolio in Q2 2026, its #722 holding.
  • Clearstead Advisors first reported a position in Oaktree Specialty Lending in Q2 2024 and has held it in 9 quarters since.
  • Clearstead Advisors's Oaktree Specialty Lending position peaked at $940K in Q2 2024.
  • 165 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.